ANI PHARMACEUTICALS, INC Property, Plant and Equipment, Gross
ANI PHARMACEUTICALS, INC (ANIP) had Property, Plant and Equipment, Gross of $77.53 million as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-02-29
- 2023-12-31: Property, Plant and Equipment, Gross $77.53M.
- 2023-03-31: Property, Plant and Equipment, Gross $70.55M.
- 2022-12-31: Property, Plant and Equipment, Gross $75.96M.
- 2022-09-30: Property, Plant and Equipment, Gross $72.94M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2023-12-31 | $77.53M 10-K · filed 2024-02-29 | |
| 2023-03-31 | $70.55M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $75.96M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $72.94M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $71.04M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $77.68M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $75.63M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $60.82M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $60.34M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $59.54M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $58.80M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $56.74M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $55.02M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $54.27M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $53.32M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $51.37M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $49.51M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $47.91M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $46.49M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $45.06M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $29.88M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $28.54M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $26.99M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $23.66M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $20.94M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $18.60M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $16.39M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $14.85M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $13.80M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $13.08M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $11.58M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $10.09M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $9.39M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $9.24M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $9.02M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $8.68M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $8.11M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $7.85M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $7.73M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $7.70M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $7.67M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $7.54M 10-K · filed 2014-02-28 | $557.95K 10-K · filed 2013-02-28 |
| 2011-12-31 | $1.29M 10-K · filed 2013-02-28 | |
| 2010-12-31 | $1.08M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |